MYSOLINE
What it isAntiepileptic with direct and phenobarbital-mediated GABA-A enhancement; essential tremor and seizures.
Why this oneWith propranolol it is one of only two first-line treatments for essential tremor.
What limits itA severe acute reaction on the first dose is common, so start at a fraction of the target. It is an enzyme inducer through its phenobarbital metabolite.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Epilepsy (grand mal, psychomotor, focal), no prior treatment | Adult & child ≥8 yr | 100-125 mg QHS | 250 mg TID | 500 mg QID (2000 mg/day) |
| Epilepsy | Pediatric <8 yr | 50 mg QHS | 125-250 mg TID (or 10-25 mg/kg/day divided) | 250 mg TID |
Titration Increase approximately every 3 days per initiation schedule (Days 1-3, 4-6, 7-9, then maintenance)
Renal Undefined
Hepatic Undefined
Target serum primidone level 5-12 mcg/mL
Pregnancy Undefined
Lactation Undefined
NO BOXED WARNINGS
Principal riskSedation; converts to phenobarbital
Cost, est. cash$5–$150/month
Generic entry2001
Legacy pregnancy categoryD
Defining liabilitySedation, dependence and phenobarbital-mediated respiratory/CNS depression in overdose.

Open Primidone in the interactive console ↗
